OTCMKTS:SHEZF Shenzhen Hepalink Pharmaceutical Group (SHEZF) Stock Price, News & Analysis → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free SHEZF Stock Alerts $0.72 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share Today's Range$0.72▼$0.7250-Day Range$0.72▼$0.7252-Week Range$0.72▼$0.72VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Shenzhen Hepalink Pharmaceutical Group alerts: Email Address Ad InvestorPlaceMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks."And these will be the biggest winners About Shenzhen Hepalink Pharmaceutical GroupShenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished dose pharmaceutical products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, such as pancreatin API. The company is also involved in the provision of research and development, manufacturing, quality management, and program management services; and development and manufacture of recombinant pharmaceutical products, critical non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical products. In addition, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; research, development, production, and sell of biopharmaceuticals; production and sale of heparin sodium; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.Read More SHEZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHEZF Stock News HeadlinesOctober 13, 2023 | wsj.comShenzhen Hepalink Pharmaceutical Group Co. Ltd. AOctober 6, 2023 | finance.yahoo.comOncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate OregovomabSee More Headlines Receive SHEZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shenzhen Hepalink Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:SHEZF CUSIPN/A CIKN/A Webwww.hepalink.com Phone86-755-2698-0200FaxN/AEmployees2,080Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Li Li (Age 60)Co-Founder, Chairman of the Board & President Comp: $409.36kMr. Yu Shan (Age 64)Co-Founder, GM, Group VP & Executive Director Comp: $364.59kMs. Tan Li (Age 60)VP, Deputy GM & Director Comp: $334.06kMs. Juan Chen (Age 49)VP of Finance, CFO & Financial Controller Ms. Tao Han M.B.A.Chief Business OfficerMr. Ping ZhangSenior Vice President of Global Industrial AffairsMr. Xi GaoSenior Vice President of Global Supply ChainMr. Fengqi Qian (Age 39)Joint Company Secretary More ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors SHEZF Stock Analysis - Frequently Asked Questions Should I buy or sell Shenzhen Hepalink Pharmaceutical Group stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Shenzhen Hepalink Pharmaceutical Group in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" SHEZF shares. View SHEZF analyst ratings or view top-rated stocks. How have SHEZF shares performed in 2024? Shenzhen Hepalink Pharmaceutical Group's stock was trading at $0.7206 at the beginning of 2024. Since then, SHEZF shares have increased by 0.0% and is now trading at $0.7206. View the best growth stocks for 2024 here. How do I buy shares of Shenzhen Hepalink Pharmaceutical Group? Shares of SHEZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHEZF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.